//New York hospitals are studying a common heartburn drug as a potential treatment for COVID-19

New York hospitals are studying a common heartburn drug as a potential treatment for COVID-19

Hospitals in New York are giving COVID-19 patients heartburn medicine to see if it helps fight the virus, according to the doctor who initiated the trial.Preliminary results of the clinical trial of famotidine, the active ingredient in Pepcid, could come out in the next few weeks, said Dr. Kevin Tracey, president of Feinstein Institutes for Medical Research at Northwell Health, which runs 23 hospitals in